Macular Disease Clinical Trial
Official title:
Standard Cut Rate 27-Gauge System Versus Ultrahigh-Speed 27-Gauge System in Macular Surgery : A Randomized Controlled Trial
The purpose of this study is to compare the efficiency and safety of ultrahigh-speed cut rate 27-gauge system (27+®GA HYPERVIT® Vitrectomy Probe (Alcon Laboratories, Fort Worth, TX, USA)) and standard cut rate 27-gauge vitrectomy system (27+®GA Advanced ULTRAVIT® Vitrectomy Probe (Alcon Laboratories, Fort Worth, TX, USA)).
During the last few decades, there have been dramatic changes in vitreoretinal surgery field with improvements in the performance of surgical retina equipment. As the innovation trend has been moving toward the smaller instrument calibers, the 27-gauge vitrectomy system has been developed. However, the vitrectomy system with the smaller calibers have limitations such as reduced instrument rigidity, limited availability of instrumentation, and decreased flow rate. To overcome these limitations, active developments have been ongoing to increase vitreous cutting speed, enlargement of the cutting port size, and enlargement of inner shaft to enable higher flow rates. Especially, the ultrahigh-speed cutter with improved cutting speed has the advantage of enabling safer vitrectomy because the faster cutting speed reduces retinal movement and minimizes the risk of iatrogenic retinal breaks. However, ultrahigh-speed cutting has a limitation in that it can reduce the flow rate through the vitreous cutter as it affects the duty cycle (percentage of time the cutter port is open relative to the complete cutting cycle). Therefore, the duty cycle of ultrahigh-speed cutter has also been improved so as not to delay the time for vitrectomy. The investigators would like to evaluate the efficiency and safety of vitrectomy using a recently released ultra high-speed cut rate 27-gauge system (27+®GA HYPERVIT® Vitrectomy Probe (Alcon Laboratories, Fort Worth, TX, USA)) and a standard cut rate 27-gauge system (27+®GA Advanced ULTRAVIT® Vitrectomy Probe (Alcon Laboratories, Fort Worth, TX, USA)) by comparing the duration of vitrectomy and the rate of complications. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01468337 -
Topical Interferon Gamma-1b for Central Serous Chorioretinopathy
|
Phase 1/Phase 2 | |
| Recruiting |
NCT03823092 -
Polarization Perception in Health and Disease. Testing a New Sight Test
|
||
| Recruiting |
NCT05130385 -
High Resolution Optical Coherence Tomography
|
||
| Completed |
NCT00994227 -
Clinicopathologic Findings for Macular Disease
|
N/A | |
| Recruiting |
NCT02081339 -
Cohort Study of the Clinical Course of Macular Diseases in Japanese
|
N/A | |
| Completed |
NCT03376776 -
Epiretinal Proliferation in Eyes With Full Thickness Macular Hole
|
N/A | |
| Enrolling by invitation |
NCT04607369 -
Implementation of the NEDS EyeCTester App
|
||
| Completed |
NCT01510392 -
CEI Van Outreach Screening Study
|
||
| Completed |
NCT00286637 -
Novel Diagnostics for Ocular Structure
|
||
| Recruiting |
NCT05588037 -
Combined Vitrectomy and Femtosecond Laser-assisted Cataract Surgery
|
N/A | |
| Completed |
NCT01853930 -
Translation of Eye Movement Reading Training to Clinical Practice
|
N/A | |
| Recruiting |
NCT02321267 -
Cohort Study of the Clinical Course of Macular Diseases in Kagawa
|
Phase 4 | |
| Terminated |
NCT01994174 -
Effect of Vascular Endothelial Growth Factor Blockers on Aqueous Humor Dynamics
|
||
| Completed |
NCT03244007 -
Evaluation of Retinal Microstructure Detected With Intraoperative Optical Coherence Tomography During Vitrectomy
|